Literature DB >> 24594085

Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes.

Giovanni Targher1, Filippo Valbusa2, Stafano Bonapace3, Lorenzo Bertolini4, Luciano Zenari4, Isabella Pichiri5, Alessandro Mantovani5, Giacomo Zoppini5, Enzo Bonora5, Enrico Barbieri3, Christopher D Byrne6.   

Abstract

BACKGROUND AND AIMS: The relationship between nonalcoholic fatty liver disease (NAFLD) and prolonged heart rate-corrected QT (QTc) interval, a risk factor for ventricular arrhythmias and sudden cardiac death, is currently unknown. We therefore examined the relationship between NAFLD and QTc interval in patients with type 2 diabetes. METHODS AND
RESULTS: We studied a random sample of 400 outpatients with type 2 diabetes. Computerized electrocardiograms were performed for analysis and quantification of QTc interval. NAFLD was diagnosed by ultrasonographic detection of hepatic steatosis in the absence of other liver diseases. Mean QTc interval and the proportion of those with increased QTc interval (defined as either QTc interval above the median, i.e. ≥416 ms, or QTc interval >440 ms) increased steadily with the presence and ultrasonographic severity of NAFLD. NAFLD was associated with increased QTc interval (odds ratio [OR] 2.16, 95% CI 1.4-3.4, p < 0.001). Adjustments for age, sex, smoking, alcohol consumption, BMI, hypertension, electrocardiographic left ventricular hypertrophy, diabetes-related variables and comorbid conditions did not attenuate the association between NAFLD and increased QTc interval (adjusted-OR 2.26, 95% CI 1.4-3.7, p < 0.001). Of note, the exclusion of those with established coronary heart disease or peripheral artery disease from analysis did not appreciably weaken this association.
CONCLUSION: This is the first study to demonstrate that the presence and severity of NAFLD on ultrasound is strongly associated with increased QTc interval in patients with type 2 diabetes even after adjusting for multiple established risk factors and potential confounders.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Arrhythmias; Cardiovascular risk; Liver fat; Nonalcoholic fatty liver disease; Type 2 diabetes

Mesh:

Year:  2014        PMID: 24594085     DOI: 10.1016/j.numecd.2014.01.005

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  26 in total

Review 1.  Cardiac abnormalities in patients with nonalcoholic fatty liver disease : Insights from auxiliary examinations.

Authors:  Yu Dong; Guangsen Li
Journal:  Herz       Date:  2019-09-19       Impact factor: 1.443

Review 2.  Extra-Hepatic Manifestations of Nonalcoholic Fatty Liver Disease: A Review.

Authors:  Raseen Tariq; Page Axley; Ashwani K Singal
Journal:  J Clin Exp Hepatol       Date:  2019-07-25

Review 3.  The Role of Non-alcoholic Fatty Liver Disease in Cardiovascular Disease.

Authors:  Sven M Francque
Journal:  Eur Cardiol       Date:  2014-07

Review 4.  Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus.

Authors:  Giovanni Targher; Amedeo Lonardo; Christopher D Byrne
Journal:  Nat Rev Endocrinol       Date:  2017-12-29       Impact factor: 43.330

5.  Increasing Adiposity Is Associated With QTc Interval Prolongation and Increased Ventricular Arrhythmic Risk in the Context of Metabolic Dysfunction: Results From the UK Biobank.

Authors:  Kiran Haresh Kumar Patel; Xinyang Li; Xiao Xu; Lin Sun; Maddalena Ardissino; Prakash P Punjabi; Sanjay Purkayastha; Nicholas S Peters; James S Ware; Fu Siong Ng
Journal:  Front Cardiovasc Med       Date:  2022-06-29

6.  Quantification of liver proton-density fat fraction in 7.1T preclinical MR systems: Impact of the fitting technique.

Authors:  Christoph Mahlke; Diego Hernando; Christina Jahn; Antonio Cigliano; Till Ittermann; Anne Mössler; Marie-Luise Kromrey; Grazyna Domaska; Scott B Reeder; Jens-Peter Kühn
Journal:  J Magn Reson Imaging       Date:  2016-05-19       Impact factor: 4.813

Review 7.  Nonalcoholic fatty liver disease as a multi-systemic disease.

Authors:  Hakan Fotbolcu; Elçin Zorlu
Journal:  World J Gastroenterol       Date:  2016-04-28       Impact factor: 5.742

Review 8.  Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease.

Authors:  Alessandro Mantovani; Stefano Ballestri; Amedeo Lonardo; Giovanni Targher
Journal:  Dig Dis Sci       Date:  2016-01-25       Impact factor: 3.199

9.  Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease.

Authors:  Lisa B VanWagner; Mary E Rinella
Journal:  Curr Hepatol Rep       Date:  2016-03-28

10.  TIMP3 interplays with apelin to regulate cardiovascular metabolism in hypercholesterolemic mice.

Authors:  Robert Stöhr; Ben Arpad Kappel; Daniela Carnevale; Michele Cavalera; Maria Mavilio; Ivan Arisi; Valentina Fardella; Giuseppe Cifelli; Viviana Casagrande; Stefano Rizza; Antonino Cattaneo; Alessandro Mauriello; Rossella Menghini; Giuseppe Lembo; Massimo Federici
Journal:  Mol Metab       Date:  2015-08-06       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.